LAI GOLDMAN MYLA (CIK 1168581) reported 9 SEC Form 4 insider transactions across 3 companies over the past 18 months (most recent 2026-07-09). Recent activity: Buy QTRX (8,073 shares), Buy WST (791 shares), Buy QTRX (23,372 shares), Buy QTRX (1,944 shares), Buy QTRX (2,084 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-09 | Quanterix Corp (QTRX) | Director | Buy | 8,073 | $0 |
| 2026-05-06 | WEST PHARMACEUTICAL SERVICES INC (WST) | Director | Buy | 791 | $0 |
| 2026-01-06 | Quanterix Corp (QTRX) | Director | Buy | 23,372 | $0 |
| 2026-01-06 | Quanterix Corp (QTRX) | Director | Buy | 1,944 | $0 |
| 2025-10-03 | Quanterix Corp (QTRX) | Director | Buy | 2,084 | $11,545 |
| 2025-07-10 | Akoya Biosciences, Inc. (AKYA) | Director | Sell | 20,000 | $0 |
| 2025-07-10 | Quanterix Corp (QTRX) | Director | Buy | 2,940 | $0 |
| 2025-07-10 | Quanterix Corp (QTRX) | Director | Buy | 24,464 | $0 |
| 2025-05-08 | WEST PHARMACEUTICAL SERVICES INC (WST) | Director | Buy | 1,071 | $0 |
Source: SEC Form 4 filings · as of 2026-07-09